Expression ofrasOncogene p21 in Prostate Cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (33)
Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.
1981 • 14,396 citations
Prediction of Prognosis for Prostatic Adenocarcinoma by Combined Histological Grading and Clinical Staging
1974 • 2,200 citations
CELLULAR ONCOGENES AND RETROVIRUSES
1983 • 1,671 citations
Mechanism of activation of a human oncogene
1982 • 1,417 citations
A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene
1982 • 1,398 citations
Cellular Oncogenes and Multistep Carcinogenesis
1983 • 1,154 citations
Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells
1985 • 913 citations
Expression of Cellular Oncogenes in Human Malignancies
1984 • 840 citations
Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family
1982 • 836 citations
Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change
1982 • 706 citations
Malignant transformation of early passage rodent cells by a single mutated human oncogene
1984 • 479 citations
Oncogenes in solid human tumours
1982 • 467 citations
Microinjection of the oncogene form of the human H-ras (t-24) protein results in rapid proliferation of quiescent cells
1984 • 401 citations
Malignant Activation of a K- ras Oncogene in Lung Carcinoma But Not in Normal Tissue of the Same Patient
1984 • 395 citations
Prostatic-specific antigen: An immunohistologic marker for prostatic neoplasms
1981 • 370 citations
The Histology and Prognosis of Prostatic Cancer
1967 • 264 citations
Monoclonal antibodies define differential ras gene expression in malignant and benign colonic diseases
1984 • 226 citations
Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary and colon carcinomas.
1984 • 223 citations
Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors.
1985 • 191 citations
Expression of p21ras in fresh primary and metastatic human colorectal tumors.
1985 • 181 citations
Altered gene products are associated with activation of cellular rasK genes in human lung and colon carcinomas
1983 • 175 citations
ras Oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma.
1985 • 173 citations
RELATION BETWEEN BENIGN PROSTATIC HYPERPLASIA AND CANCER OF THE PROSTATE
1974 • 140 citations
Cancer of the Prostate Among Men With Benign Prostatic Hyperplasia 2
1974 • 138 citations
Evaluation of Prostate Specific Acid Phosphatase and Prostate Specific Antigen in Identification of Prostatic Cancer
1983 • 93 citations
Multiple Immunoperoxidase Markers in Benign Hyperplasia and Adenocarcinoma of the Prostate
1984 • 90 citations
Carcinoembryonic antigen in patients with tumors of the urogenital tract
1972 • 86 citations
Differential Binding to Human Mammary and Nonmammary Tumors of Monoclonal Antibodies Reactive with Carcinoembryonic Antigen
1983 • 79 citations
Pathologic differentiation and prognosis of prostatic carcinoma
1969 • 28 citations
Immunofluorescence for Prostatic Acid Phosphatase: Clinical Applications
1981 • 22 citations
Prostatic carcinoma Relationship betwen primary tumor, Histologic grade, and response to chemotherapy☆
1976 • 14 citations
A histochemical study of glycosidases in benign prostatic hyperplasia and in prostatic carcinoma in the human
1978 • 10 citations
Relationship between Prostatic Cytoplasmic and Nuclear Androgen Receptors in Patients with Carcinoma of the Prostate
1981 • 5 citations
Cited By (0)
No citing papers found in database